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Total Synthesis of (–)-Nakadomarin A 
J. Stephen Clark* and Chao Xu  
Abstract: A highly efficient 12-step synthesis of the marine alkaloid 
(−)-nakadomarin A has been accomplished. The key advanced 
intermediate, tetracyclic ketone 13, was constructed in just seven 
steps using a sequence that includes an asymmetric Pauson-Khand 
reaction, an Overman rearrangement reaction, a ring-closing 
metathesis reaction and an amination reaction. Late introduction of 
the furan (ring C) during the synthesis of (−)-nakadomarin A means 
that the tetracyclic ketone 13 has the potential to serve as an 
advanced intermediate for the synthesis of related marine alkaloids. 
(−)-Nakadomarin A (1) was first isolated from a sponge of 
Amphimedon sp. by Kobayashi and co-workers in 1997 and was 
found to possess a unique hexacyclic structure featuring fused 
5-, 6-, 8- and 15-membered rings (Figure 1).[1] This alkaloid 
exhibits cytotoxicity against murine lymphoma L1210 cells, 
antimicrobial activity and inhibitory activity against cyclin-
dependent kinase 4.[2] The intriguing structure of nakadomarin A 
(1) combined with its significant biological activity and limited 
availability make it a very attractive target for total synthesis, a 
fact that is reflected by the many studies that have been devoted 
to its synthesis.[3] To date, seven enantioselective total 
syntheses have been reported.[4] Following the original 
pioneering syntheses of nakadomarin A completed by the 
groups of Nishida[4a,b]  and Kerr,[4c] impressive and innovative 
syntheses have been reported by the groups of Dixon[4d,g–i] and 
Evans,[4j] which set the benchmark with respect to efficiency.  
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Figure 1. Selected members of the manzamine family of marine alkaloids. 
Nakadomarin A is classified as a member of the manzamine 
family of alkaloids, even though it is architecturally distinct from 
the other members because it possesses a furan and a 
contracted B-ring. Kobayashi and co-workers proposed a direct 
biosynthetic route from iricinal A to nakadomarin A,[1] which 
suggests that a common synthetic approach to both compounds 
might be possible. In all previous syntheses of nakadomarin A, a 
furan-containing starting material has been used or the furan 
has been constructed very early in the route.[4] We wanted to 
design a synthesis in which an advanced intermediate could 
also be used to synthesize many of the other manzamine 
alkaloids. Such a strategy would preclude the use of a 
functionalized furan as the starting material and would require 
construction of the C-ring relatively late in our synthesis.  
Our strategy for the synthesis of nakadomarin A (1) and the 
other manzamine alkaloids evolved from the retrosynthetic 
analysis shown in Scheme 1. Disconnection through the alkene 
of ring F leads to the triene i. Replacement of the N-alkyl group 
with a protecting group in ring A gives the diene ii and 
disconnection of ring C reveals the key tetracyclic ketone iii. In 
the cases of manzamine A (2) and ircinal A (3), disconnection of 
the D-ring alkene and removal of the B-ring substituent (R1) 
leads to the enone iv; subsequent retrosynthetic contraction of 
ring B delivers the ketone iii. Thus, retrosynthetic analyses for 
all three natural products converge on the tetracyclic ketone iii 
as an intermediate. It should be noted that the forward sequence 
of reactions, in which the ketone iii is converted into the enone 
iv, is in essence the reverse of the proposed biosynthetic 
process by which ircinal A is converted into nakadomarin A.[1] 
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Scheme 1. Retrosynthetic analysis of nakadomarin A (1), manzamine A (2) 
and ircinal A (3) via the tetracyclic ketone iii. 
Disconnection of the C-N bond in ring D that links rings B 
and E in nakadomarin A leads to tricyclic amino ketone v and 
implies an unusual electrophilic amination reaction in the 
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forward direction. Cleavage through the alkene in ring E 
furnishes the diene vi and further disconnection gives the allylic 
alcohol vii and the protected ω-amino alkene viii. Scission of the 
alkene in the allylic alcohol vii affords the ketone ix and the 
protected allylic alcohol x. Removal of the allyl chain then 
reveals the bicyclic enone xi as an early synthetic intermediate.[5] 
Our synthesis of (–)-nakadomarin A (1) commenced from the 
known enyne 4,[6] which was prepared by alkylation of 
commercially available N-tosyl propargylamine with 4-bromobut-
1-ene (Scheme 2).[5] The enyne 4 was converted into the fused 
bicyclic enone 5 in good yield and with excellent ee using the 
asymmetric cobalt-catalysed Pauson-Khand reaction developed 
by Hiroi and co-workers.[7] Reaction of the enone 5 with the 
organocopper reagent generated from allylmagnesium chloride 
and copper(I) iodide resulted in a highly diastereoselective 
conjugate addition reaction and established the quaternary 
stereogenic centre at the AB ring junction. The resulting terminal 
alkene 6 was functionalised by cross-metathesis with the silyl-
protected allylic alcohol 7 to give the allylic alcohol 8 in high yield 
after desilylation during acidic work-up. 
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Scheme 2. Synthesis of the functionalised AB ring system using a Pauson-
Khand reaction and subsequent installation of functionality using an Overman 
rearrangement reaction. a) Co2(CO)8, (R)-BINAP, CO, then NMO, PhMe, 
65 °C, 72% (97% ee); b) CH2CHCH2MgCl, CuI, LiCl, TMSCl, THF, –10 °C, 
91%; c) 7, Hoveyda-Grubbs II catalyst (3 mol %), CH2Cl2, reflux, then 1M HCl, 
85%; d) NaHMDS, 9, THF, –30 °C then K2CO3, PhMe, reflux, 73%. 
The stage was now set for introduction of the allylic amine 
using an Overman rearrangement reaction.[8,9] A solution of the 
alcohol 8 in THF was deprotonated and the resulting alkoxide 
was treated with the imidoyl bromide 9 at – 30 °C.[10] After 
complete formation of the trifluoroacetimidate 10, potassium 
carbonate was added and the mixture was diluted with toluene, 
then heated at reflux for two days. The one-pot imidate 
formation and [3,3]-sigmatropic rearrangement reaction afforded 
the trifluoroacetamide 11 as a single diastereomer in 73% yield. 
Construction of ring E was accomplished by use of a ring-
closing metathesis reaction (RCM). Treatment of the diene 11 
with the Grubbs second-generation catalyst (15 mol %) 
delivered the azocine in 81% yield (Scheme 3). Subsequent 
base-mediated cleavage of the trifluoroacetamide afforded the 
tricyclic amine 12 and closure of ring D was performed by 
treatment of this compound with pyrrolidone hydrotribromide and 
DMAP. This reaction delivered the crystalline ketone 13 in 
excellent yield, the structure of which was confirmed by X-ray 
crystallography.[11] A related procedure has been used by Kreis 
and Carreira during their synthesis of the alkaloid natural 
product dendrobine and there is an earlier literature precedent 
for this reaction from the Rabe and Kindler synthesis of 
quinine.[12] In our case, it is not clear whether C–N bond 
formation occurs by attack of an enol on an N-bromoamine or 
results from displacement of bromide from the ±-bromoketone 
by the E-ring amine.  
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Scheme 3. Sequential construction of rings E and D. a) Grubbs II catalyst (15 
mol %), CH2Cl2, reflux, 81%; b) 10% K2CO3 aq., MeOH, rt, 88%; c) pyrrolidone 
hydrotribromide, DMAP, THF, rt, 90%. 
Construction of the ketone 13, which corresponds to the 
complete tetracyclic ABDE core of nakadomarin A, meant that 
introduction of the remaining carbon framework required for 
construction of rings C and F could be explored (Scheme 4). 
Regioselective deprotonation of the ketone 13 with LDA, 
followed by aldol condensation of the lithium enolate with the 
aldehyde 14[13] afforded the enone 15 in 46% yield.[14,15] Acid-
mediated cleavage of the TBS protecting group with concomitant 
dehydrative cyclisation delivered the furan 16.[16] 
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Scheme 4. Attempted synthesis of the diamino acid substrate required for 
macrolactamisation to form ring F. a) LDA, 14, THF, –78 °C, 46%; b) TsOH, 
PhMe, rt, 95%; c) Na, naphthalene, DME, –78 °C then sat. LiOH aq., rt. 
The next challenge was to remove the tosyl protecting group 
and cleave the methyl ester, thereby generating the amino acid 
required to close ring F by a macrolactamization reaction. A one-
pot sulfonamide cleavage and saponification sequence was 
performed in which the N-tosyl amine 16 was treated with 
sodium naphthalenide and then lithium hydroxide solution was 
added to hydrolyse the ester. Unfortunately, the highly polar 
amino acid 17 was not isolated and so it was necessary to 
implement an alternative end-game strategy.  
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The aldehyde 18 was prepared[17] and then subjected to an 
aldol condensation reaction with the lithium enolate generated 
from the ketone 13 (Scheme 5). The aldol condensation reaction 
delivered the enone 19[15] and this compound was then 
converted into the furan 20 in good yield by acid-mediated 
desilylation, cyclization and dehydration.[16] Subsequent one-pot 
cleavage of the sulfonamide and N-acylation with 5-hexenoyl 
chloride delivered the amide 21 as a mixture of rotamers. 
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Scheme 5. Synthesis of the final ring-closing metathesis precursor. a) LDA, 18, 
THF, –78 °C, 50%; b) TsOH, PhMe, rt, 93%; c) Na, naphthalene, DME, –78 °C, 
then CH2CH(CH2)3COCl, Et3N, 90%. 
Reduction of amide 21 with Red-Al delivered the diamine 22 
in 81% yield (Scheme 6). The diamine 21 featured as the final 
intermediate in the synthesis of (–)-nakadomarin A published by 
Dixon and co-workers; spectroscopic and other data for our 
sample of triene 22 were identical to those reported 
previously.[4d] The triene 22 was then subjected to the RCM 
reaction under conditions described by Dixon and co-workers 
and a mixture of (−)-nakadomarin A (1) and its E isomer 23 was 
obtained in 38% yield. 
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Scheme 6. Completion of the synthesis of nakadomarin A. a) Red-Al, PhMe, 
reflux, 81%; b) Grubbs I catalyst (15 mol %), camphor sulfonic acid, CH2Cl2, 
reflux, 38% (1 + 23). c) Grubbs II catalyst (15 mol %), CH2Cl2, reflux, 80% 
(60:40 Z-24:E-24); d) Red-Al, PhMe, reflux, 1 89%, 23 84%. 
The modest yield for the final RCM reaction and that fact that 
nakadomarin A (1) could not be separated from the E-isomer 23 
without recourse to HPLC prompted us investigate reversal of 
the final two steps in the synthesis (Scheme 6). Direct 
macrolactam formation by RCM of the amide 21 delivered a 
mixture of Z-24 and E-24 in high yield. To our delight, it was 
found to be possible to separate the alkene isomers using 
conventional chromatography on basic alumina and so pure 
samples of both isomeric lactams were obtained. Interestingly, 
Z-selectivity was achieved using the Grubbs second-generation 
catalyst (60:40, Z:E), whereas a reversal of selectivity (40:60, 
Z:E) was observed when the RCM reaction was performed using 
the Grubbs first-generation catalyst. The synthesis of (–)-
nakadomarin A (1) was completed by reduction of the lactam 
Z-24 using Red-Al in toluene at reflux. The spectroscopic data 
(1H NMR and 13C NMR), high-resolution mass spectrometric 
data, and specific rotation of our synthetic material were in 
excellent agreement with the published data for the natural 
product.[1,4]  
In conclusion, we have developed a concise and 
stereoselective synthesis of (–)-nakadomarin A (1) from the 
simple acyclic enyne 4 (longest linear sequence 12 steps). The 
tetracyclic intermediate 13 was synthesized enantioselectively in 
just seven steps, with high efficiency and overall yield. The 
ketone 13 has the potential to serve as a common late-stage 
intermediate for the synthesis of other manzamine alkaloids, 
such as manzamine A (2) and ircinal A (3). The application of 
our synthetic strategy to the total synthesis other manzamine 
alkaloids will be reported in due course. 
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